Mark Farber, M.D., Ph.D.
Director of Research and Development, SHMG
Dr. Mark Farber is a hospitalist physician and Director of Research and Development with the Stanford Hospitalist Medical Group at Cedars Sinai. Dr. Farber began his career as a chemical engineer working for several small biotech firms in the Boston area. His engineering experience drove his interest in medical science and in 2004 he began the Medical Scientist Training Program at SUNY Downstate in New York. As a PhD candidate in the departments of biomedical engineering and behavioral neuroscience, Dr. Farber developed a new brain imaging technology using infra-red light that was awarded the Kirschstein NIH National Research Service Award and was subsequently developed into new brain imagers for monitoring blood flow in the brain during surgery and measuring blood flow in the brain to move a robotic arm. Dr. Farber received his MD in addition to his PhD in biomedical engineering in 2013 and subsequently completed his internship and residency at the University of South Florida, where he excelled as a physician and clinical researcher.
Dr. Farber also serves as the Director of Research and Development for the Stanford Hospitalist Medical Group, and has the responsibility of applying his science and engineering experience to help physicians in the group minimize burden of paperwork and maximize efficiency and quality of care. Dr. Farber has 20 years of experience in biomedical research and has worked at many prestigious institutions around the country including the NIH, Harvard Medical School and Brown University among others. His dynamic interests in research have resulted in multiple publications at high impact journals in the fields of immunology, oncology, biomaterials, optical imaging, neuroscience, stem cells and tissue engineering.
Dr. Farber strives to provide the highest quality care in the hospital setting. He enjoys spending time with his family, reading and exploring LA. Dr. Farber is also an entrepreneur and is actively involved in several business projects to develop new devices and software to improve physician efficiency, cut costs and maximize patient compliance. Dr. Farber is an immigrant from Russia and speaks Russian fluently.